CCBIO ASCPO Needle— 510(k) K214004

Substantially Equivalent

Cc Biotechnology Corporation

FDA 510(k) clearance K214004 for CCBIO ASCPO Needle, Substantially Equivalent on 2022-12-13. Applicant: Cc Biotechnology Corporation. Device class: 2.

Clearance details

Applicant
Cc Biotechnology Corporation
Product code
Code FMI
Device class
Class 2
Regulation
21 CFR 880.5570
Advisory panel
General Hospital
Date received
Decision date
Decision
Substantially Equivalent
Clearance type
Traditional
Location
Tainan, TW
Download summary PDFView on FDA.gov ↗

Recent devices under product code FMI

view all

Adverse events under product code FMI

product code FMI
Death
28
Injury
1,517
Malfunction
23,981
Other
18
Total
25,544

Source: openFDA MAUDE database, through . Counts aggregate all devices under this product code, not just this specific clearance. Reports are submissions to FDA, not validated events. Search MAUDE directly →

Data sourced from openFDA. This site is unofficial and independent of the FDA.